Wheeler Bio is a pioneering CDMO focused on accelerating the discovery-to-development process for biopharmaceutical companies. Wheeler specializes in biologics development, mammalian cell culture, GLP material supply, and cGMP drug substance production for preclinical and clinical supply. The company’s modular CMC platform is purpose-built for early development and clinical manufacturing while also supporting future, scalable commercial production. Based in Oklahoma City, Oklahoma, Wheeler Bio's 35,000-sq.-ft. cGMP manufacturing facility leverages an open ballroom design, closed-process, and digitally connected equipment for maximum flexibility, transparency, and speed.
